Nektar TherapeuticsNKTRNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank100
3Y CAGR+42.1%
5Y CAGR+40.3%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+42.1%/yr
vs +12.7%/yr prior
5Y CAGR
+40.3%/yr
Consistent
Acceleration
+29.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.4x
Strong expansion
Streak
5 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.53+57.3%
20240.34+14.1%
20230.30+59.9%
20220.19+44.4%
20210.13+31.2%
20200.10-52.7%
20190.21+79.7%
20180.11-76.2%
20170.48+10.3%
20160.44-